Skip to Main Content

Paper Details

Frequency and Outcomes of Reduced Dose Non-Vitamin K Antagonist Anticoagulants: Results From ORBIT-AF II (The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II).
J Am Heart Assoc
126
2018
AF, Atrial Fibrillation, NOAC, Vitamin K, atrial fibrillation, patient, patients, stroke, thromboembolic events, vitamin K
Author NameAffiliation
Benjamin A SteinbergUniversity of Utah Health Sciences Center
Peter ShraderDuke Clinical Research Institute
Gregg C Fonarowuniversity of california los angeles Division of Cardiology
Gregg C Fonarowuniversity of california los angeles Division of Cardiology
Bernard J GershMayo Clinic
Kenneth W MahaffeyStanford University School of Medicine
Daniel E SingerHarvard Medical School and Massachusetts General Hospital
Eric D PetersonDuke Clinical Research Institute
Eric D PetersonDuke University Medical Center
Eric D PetersonDuke Clinical Research Institute
Eric D PetersonDuke University Medical Center
Jonathan P PicciniDuke Clinical Research Institute
Jonathan P PicciniDuke University Medical Center
  • 1 - 13

Datasets

Release 1.2